Skip to main content
Log in

Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population

  • Short Communication
  • Published:
Environmental Health and Preventive Medicine Aims and scope

Abstract

Objectives

RNF213 p.R4810K is a founder polymorphism that confers genetic susceptibility to moyamoya disease in East Asia. Only a few studies have investigated the symptoms and disease histories of RNF213 p.R4810K carriers in Japan. This study investigated the frequency of RNF213 p.R4810K in the general Japanese population and the health characteristics of the carriers.

Methods

Through a health-promotion campaign in the city of Uji, Japan, 519 subjects (120 males and 399 females) of the general Japanese population were genotyped for RNF213 p.R4810K and interviewed to determine health characteristics.

Results

Nine RNF213 p.R4810K heterozygous carriers (GA genotype) and no RNF213 p.R4810K homozygous carriers (AA genotype) were found among the 519 individuals. The estimates of the genotypes and allele frequencies for RNF213 p.R4810K were 1.73 and 0.87 %, respectively. There were no obvious differences in age, gender ratio, body mass index, hypertension, dyslipidemia, diabetes, kidney disease, liver disease, heart disease, or drinking or smoking habits between carriers and non-carriers. Interestingly, one patient with moyamoya disease was found among the nine RNF213 p.R4810K carriers.

Conclusions

This study showed the genotypes and allele frequencies of RNF213 p.R4810K in the general Japanese population to be similar to results of previous reports.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Suzuki J, Takaku A. Cerebrovascular, “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20(3):288–99. doi:10.1001/archneur.1969.00480090076012.

    Article  CAS  PubMed  Google Scholar 

  2. Scott RM, Smith ER. Moyamoya disease and moyamoya syndrome. N Engl J Med. 2009;360(12):1226–37. doi:10.1056/NEJMra0804622.

    Article  CAS  PubMed  Google Scholar 

  3. Miao W, Zhao PL, Zhang YS, Liu HY, Chang Y, Ma J, et al. Epidemiological and clinical features of moyamoya disease in Nanjing, China. Clin Neurol Neurosurg. 2010;112(3):199–203. doi:10.1016/j.clineuro.2009.11.009.

    Article  PubMed  Google Scholar 

  4. Ahn IM, Park DH, Hann HJ, Kim KH, Kim HJ, Ahn HS. Incidence, prevalence, and survival of moyamoya disease in Korea: a nationwide, population-based study. Stroke. 2014;45(4):1090–5. doi:10.1161/STROKEAHA.113.004273.

    Article  PubMed  Google Scholar 

  5. Hoshino H, Izawa Y, Suzuki N. Epidemiological features of moyamoya disease in Japan. Neurol Med Chir (Tokyo). 2012;52(5):295–8. doi:10.2176/nmc.52.295.

    Article  Google Scholar 

  6. Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, Kikuchi A, et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet. 2011;56(1):34–40. doi:10.1038/jhg.2010.132.

    Article  CAS  PubMed  Google Scholar 

  7. Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, Hitomi T, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE. 2011;6(7):e22542. doi:10.1371/journal.pone.0022542.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Miyatake S, Miyake N, Touho H, Nishimura-Tadaki A, Kondo Y, Okada I, et al. Homozygous c.14576G > A variant of RNF213 predicts early-onset and severe form of moyamoya disease. Neurology. 2012;78(11):803–10. doi:10.1212/WNL.0b013e318249f71f.

    Article  CAS  PubMed  Google Scholar 

  9. Liu W, Hitomi T, Kobayashi H, Harada KH, Koizumi A. Distribution of moyamoya disease susceptibility polymorphism p.R4810K in RNF213 in East and Southeast Asian populations. Neurol Med Chir (Tokyo). 2012;52(5):299–303. doi:10.2176/nmc.52.299.

    Article  Google Scholar 

  10. Koizumi A, Kobayashi H, Liu W, Fujii Y, Senevirathna ST, Nanayakkara S, et al. P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure. Environ Health Prev Med. 2013;18(2):121–9. doi:10.1007/s12199-012-0299-1.

    Article  CAS  PubMed  Google Scholar 

  11. Miyawaki S, Imai H, Shimizu M, Yagi S, Ono H, Mukasa A, et al. Genetic variant RNF213 c.14576G > A in various phenotypes of intracranial major artery stenosis/occlusion. Stroke. 2013;44(10):2894–7. doi:10.1161/STROKEAHA.113.002477.

    Article  CAS  PubMed  Google Scholar 

  12. Jang M, Shin S, Yoon J, Ki C. Frequency of the moyamoya-related RNF213 p.Arg4810Lys variant in 1,516 Korean individuals. BMC Med Genet. 2015;16:109. doi:10.1186/s12881-015-0252-4.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Wu Z, Jiang H, Zhang L, Xu X, Zhang X, Kang Z, et al. Molecular analysis of RNF213 gene for moyamoya disease in the Chinese Han population. PLoS ONE. 2012;7(10):e48179. doi:10.1371/journal.pone.0048179.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

This study was supported by The Japan Society for the Promotion of Science KAKENHI [Grants-In-Aid for Scientific Research (A): 25253047 to AK and for Encouragement of Young Scientists (B): 15K19243 to HK] (http://www.jsps.go.jp/english/) and by a grant from the Research Committee on Spontaneous Occlusion of the circle of Willis of the Ministry of Health, Labour and Welfare of Japan (No. H26-Nanjito-Ippan-078) (http://www.mhlw.go.jp/english/policy/other/research-projects/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Akio Koizumi.

Ethics declarations

Conflict of interest

Prof. Koizumi has a registered patent regarding MMD: JP2010068737 ‘MOYAMOYA DISEASE-RELATED GENE AND UTILIZATION OF SAME’. No conflicts of interests exist for the other authors.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cao, Y., Kobayashi, H., Morimoto, T. et al. Frequency of RNF213 p.R4810K, a susceptibility variant for moyamoya disease, and health characteristics of carriers in the Japanese population. Environ Health Prev Med 21, 387–390 (2016). https://doi.org/10.1007/s12199-016-0549-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12199-016-0549-8

Keywords

Navigation